Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) material:
SEC Accession No. 0001193125-22-275341
Filing Date
2022-11-02
Accepted
2022-11-02 06:09:59
Documents
1

Document Format Files

Seq Description Document Type Size
1 DEFA14A d408267ddefa14a.htm DEFA14A 22174
  Complete submission text file 0001193125-22-275341.txt   23154
Mailing Address 500 FAIRVIEW AVENUE NORTH, SUITE 600 SEATTLE WA 98109
Business Address 500 FAIRVIEW AVENUE NORTH, SUITE 600 SEATTLE WA 98109 206-456-2900
Silverback Therapeutics, Inc. (Filer) CIK: 0001671858 (see all company filings)

EIN.: 811489190 | State of Incorp.: DE | Fiscal Year End: 1231
Type: DEFA14A | Act: 34 | File No.: 001-39756 | Film No.: 221352184
SIC: 2834 Pharmaceutical Preparations